A growing community with a shared vision Earlier this month, over 150 researchers from across McGill and partner institutions came together at Le Centre Sheraton for the inaugural DNA to RNA (D2R) Research Symposium. McGill’s Vice President,...

🌿🌎A growing community with a shared vision

150+ researchers, experts, students, & partners gathered for the inaugural #D2RSymposium2025 earlier this month to share & discuss research advancing #RNAtherapeutics & #genomicmedicine.

More on the event: www.mcgill.ca/dna-to-rna/a...

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer Montreal, March 26, 2025 – McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapi...

At #D2RSymposium2025, we announced the Translational Impact Research awards! These projects aim to revolutionize #RNA therapy, rare diseases, and cancer research. 🧬💉🔬Each will receive $3M+ for research & training!

👉 Learn more: mcgill.ca/dna-to-rna/c...

@rimuhc.bsky.social @mcgillgci.bsky.social

Huge congrats to our very own Dan Boghici for winning first prize in the #D2RSymposium2025 poster competition!

🎙️That’s a wrap for #D2RSymposium2025! Ended with an open mic with D2R’s leadership & announced poster winners!

Big thanks to our speakers, judges, presenters, attendees & sponsors: Illumina, Moderna, Deep Genomics. TriLink, BioVectra, Oxford Nanopore, adMare, Roche and Charles River.

Talking #DataScience at the #D2RSymposium2025. We learned about research that combines a video game & biology to combat diseases, gene splicing, a new Health Data Science Platform at @mcgill.ca and RNA sequencing from
@nanoporetech.com.

Inspiring #EDI session at #D2RSymposium2025!
“Diverse teams enhance innovation & problem-solving.”
A panel of @mcgill.ca experts highlighted:
• How EDI is shaping health research
• D2R’s EDI vision and action plan
• Examples how EDI is being integrated into D2R research.

Starting #D2RSymposium2025, day ✌️, #RNAtherapeutics session chaired by M. McKeague.

🔊: N. Moitessier on RNA-targeting, G. Rouleau on CRISPR tech, K. Choquet (@usherbrooke.bsky.social) on pre-mRNA splicing, J. Frtiz on iCELL platform, B. Hudson, TriLink, on next-gen mRNA design!

Day 1 #D2RSymposium2025 wraps up with inspiring presentations on mRNA translation, #RNA splicing, RNA production technologies, infectious disease platforms & AI platforms to predict biology.

Stay tuned for Day 2 updates tomorrow!

👩‍🎓👨‍🎓 A highlight of #D2RSymposium2025 is student trainees presenting D2R projects through poster presentations. Inspiring to see the next generation of researchers contributing to the conversation on #RNAtherapies!

View the list of poster presentations: www.mcgill.ca/dna-to-rna/c...

At the #D2RSymposium2025, so far we’ve heard:
✔️ @mcgill.ca's LNP design research & a core platform on end-to-end sequencing for RNA therapies
✔️ llumina's multi omics assays
✔️ @usherbrooke.bsky.social on RNA anti-cancer therapies
✔️ UBC's research on a probe for optimizing RNA delivery

🌟 The #D2RSymposium2025 kicked off with remarks from
@mcgill.ca's VPRI & D2R's CSO. Next D2R partners spoke about:
🧬 @usherbrooke.bsky.social: RNA group
🔬 UBC: Nanocore
🤝 QC NEIHR: best practices for Indigenous health research
🌍 McGill Genome Centre: D2R’s international partners

🌟 The D2R Research Symposium 2025 is officially underway!

Today & tomorrow we will post highlights of the event including inspiring talks, innovative research and poster presentations about #RNAtherapeutics. 💡

Follow #D2RSymposium2025 for updates.

mcgill.ca/dna-to-rna/c...